AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy

RecruitingPhase 2Ages 18 Years - anyAllCentre Francois Baclesse
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

We are proposing a randomized phase II study to assess the benefit of bilateral robot-assisted or laser basal tongue mucosectomy in combination with tonsillectomy in the assessment of prevalent cervical lymphadenopathy

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient with a prevalent head and neck lymphadenopathy with positive or non-contributory fine needle aspiration, or having had an adenectomy revealing a metastasis of squamous cell carcinoma, a PET examination, an injected cervico-thoracic CT and an ENT work-up (nasofibroscopy) not finding a primary tumor * Performance Status \< 2 * Patient aged 18 or over * Patient affiliated with social security system * Informed consent signed Exclusion Criteria: * History of squamous cell carcinoma of the VADS or skin of the face. * History of cervico-facial radiotherapy * Primary tumor discovering during pan-endoscopy * Inexposable patient lead not to possible mucosectomy * Uncontrollable hemostasis disorders (contraindication to tonsillectomy and basic bilateral mucosectomy of language) * Distant metastases * Lymphadenopathy inoperable * Patient with a contraindication to radiotherapy * Pregnant or breastfeeding woman * Women of childbearing potential without effective contraception * Patient under guardianship or unable to give informed consent * Patient unable to undergo the trial follow-up for geographic, social or psychopathological reasons
๐Ÿ’Š

What it tests

  • bilateral mucosectomy + tonsillectomy
  • tonsillectomy
๐Ÿ“

Where

5 sites
Centre Franรงois Baclesse
Caen, France
CHU CAEN
Caen, France
Centre Oscar Lambret
Lille, France
Chru Lille
Lille, France
CHU Rouen
Rouen, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy